In short. The risks of a lower-heat erbium plan: prolonged pinpoint bleeding, infection while the surface is open, cold-sore reactivation, and pigment that shifts.
Key points
- Less residual heat means a shorter red phase and less pigment risk than a heat-heavier ablation.
- It does not mean the surface stays intact, and it does not remove infection or scarring from the consent list.
- Anyone describing this treatment as risk-free is describing a different procedure, or selling one.
A lower-heat plan carries the risks any open surface carries, plus one or two of its own. The useful way to read them is by what changes the decision: which are common enough to plan around, which are rare but serious, and which mean the treatment is not right for you.
Pinpoint bleeding and oozing
Because the surface is left open rather than sealed by heat, the treated area often oozes and bleeds in pinpoints for some hours on the day. That is expected. Bleeding that continues well beyond the first day or two, or that restarts after it had settled, is not, and should be reviewed rather than managed at home.
Infection while the surface is open
Open skin can become infected, and the risk is highest in the first days. Antiviral cover is ordinarily prescribed, because a cold sore erupting across healing skin can leave a scar behind it, and bacterial infection is treated promptly once recognised. Increasing pain after the third day, spreading redness, heat, discharge or a fever are the signs to act on.
Lower heat lowers some risks, not all of them
Less residual heat means a shorter red phase and less pigment risk than a heat-heavier ablation. It does not mean the surface stays intact, and it does not remove infection or scarring from the consent list. Anyone describing this treatment as risk-free is describing a different procedure, or selling one.
Pigment that shifts
Pigment can move in either direction. Darkening after treatment is the common one; it appears in the weeks after the surface closes, is more frequent and more stubborn in darker skin, and can take months to settle with protection and prescribed creams. Lightening is uncommon, sometimes lasting, and has no reliable correction, which is why depth is chosen conservatively in the first place.
A visible border
Treating one region can leave a line where treated skin meets untreated skin, particularly as the treated area reddens and then fades. It usually softens with time but can persist, and it is one reason a whole-face plan is sometimes chosen over treating only the area that bothers you.
Scarring
Uncommon but real, and no lower on a gentler plan. Risk rises after infection, after treatment that was too deep for the skin, on thin skin such as the neck, and in people who form raised scars. A scar that does form can be treated but not erased, so avoiding one matters more than correcting one afterwards.
Seek review rather than reassurance when
- Pain increases after the third day, or one patch is much hotter than the rest.
- You develop a fever, spreading redness, or discharge from the treated area.
- Blistering appears, a sore fails to crust like the rest, or a cold sore breaks out.
None of this is a reason to refuse the treatment for everyone. It is a reason to have the consent conversation properly, and to treat a plan that mentions no risk at all as information about the clinic rather than about the treatment.
Frequently asked questions
What are the signs of infection after erbium resurfacing?
Pain that increases after the third day instead of easing, redness or heat spreading beyond where it was, discharge that smells, and a fever. Cold sores erupting across healing skin are a particular concern, which is why antiviral cover is ordinarily prescribed. Infection treated early usually settles without lasting harm; ignored, it can leave a scar.
Can pigment loss after erbium be corrected?
There is no reliable way to bring pigment back once the cells that make it are gone. Lightening after treatment is uncommon, it is more likely after repeated or deep treatment and after a complication such as infection, and it can leave treated skin paler than the skin around it. Camouflage is possible; reversal is not.
What causes a visible line at the edge of a treated area?
Where treated skin meets untreated skin, the difference can become visible as the treated area reddens, heals and then fades. It usually softens over months, but it can persist. Treating the whole face evenly, or feathering the passes at the edge of a region rather than stopping abruptly, is how it is avoided rather than corrected afterwards.
Risks & Limitations
- The surface is left open rather than sealed by heat, so pinpoint bleeding and oozing on the treatment day are expected; bleeding continuing beyond the first day or two needs review.
- Infection of open skin is the risk of the first days, which is why antiviral cover is ordinarily prescribed; increasing pain after the third day, spreading redness or fever needs same-day review.
- Pigment can shift in either direction: darkening is more common, more stubborn in darker skin, and can take months to settle, while lightening is uncommon and may not recover.
- A visible border can remain where treated skin meets untreated skin, and it is the one change on this list that time does not reliably soften.
- Scarring is uncommon but real, and no lower on a gentler plan; risk rises after infection, after treatment too deep for the skin, on thin skin, and in people who form raised scars.
- Each pass removes tissue that does not come back, so the number of times one area can be treated has a ceiling, and less residual heat means less tightening and less change in deep folds.
When to Seek Care
- Pain that increases after the third day instead of easing, or one patch much hotter and more swollen than the rest.
- Fever, spreading redness, or discharge from the treated area.
- Bleeding that continues beyond the first day or two, or that restarts after it had settled.
- A cold sore erupting across healing skin, which should be reported the same day.
- Blistering, dusky or grey patches, or a sore that is not crusting like the rest of the face.
References & Further Reading
- American Society for Laser Medicine and Surgery (ASLMS) — patient information on laser and energy-based treatment
- American Academy of Dermatology (AAD) — guidance on laser resurfacing and post-inflammatory hyperpigmentation
- National Institute for Health and Care Excellence (NICE, UK) — relevant guidance on skin treatments
- Cochrane Library — systematic reviews in skin resurfacing and scar management
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.